Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmaKodex

This article was originally published in The Tan Sheet

Executive Summary

A collaboration between Vectura and Unilever has resulted in the formation of the new PharmaKodex specialty pharmaceutical company, the firms announce May 15. The new entity will employ a range of proprietary oral, transdermal and enabling technologies from both companies to develop a pipeline of Rx and OTC products. Currently, the pipeline contains six nonprescription drugs in development. PharmaKodex plans to repurpose "existing drugs for new indications or combinations, or to provide an improved route of administration," according to the release. Vectura and Unilever both will "retain a significant shareholding in PharmaKodex," the firms state...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099398

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel